G. Viggiano

705 total citations
16 papers, 525 citations indexed

About

G. Viggiano is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, G. Viggiano has authored 16 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Internal Medicine. Recurrent topics in G. Viggiano's work include Bladder and Urothelial Cancer Treatments (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Sexual function and dysfunction studies (3 papers). G. Viggiano is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Sexual function and dysfunction studies (3 papers). G. Viggiano collaborates with scholars based in Italy, Belgium and Netherlands. G. Viggiano's co-authors include M. De Pauw, L. Denis, Richard Sylvester, Philip H. Smith, Otilia Dalesio, R. Sylvester, Claude C. Schulman, B Lardennois, M. Pavone‐Macaluso and H. J. de Voogt and has published in prestigious journals such as The Journal of Urology, European Urology and Journal of Cardiovascular Pharmacology.

In The Last Decade

G. Viggiano

13 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Viggiano Italy 11 263 159 78 63 56 16 525
J. M. Dubernard France 16 505 1.9× 111 0.7× 35 0.4× 35 0.6× 9 0.2× 56 798
Robert Nathan Slotnick United States 14 328 1.2× 98 0.6× 28 0.4× 10 0.2× 63 1.1× 21 772
Paul Fredlund United States 11 72 0.3× 36 0.2× 54 0.7× 30 0.5× 37 0.7× 15 587
Pietro Cignini Italy 15 176 0.7× 42 0.3× 44 0.6× 13 0.2× 37 0.7× 49 721
Lois Eva New Zealand 14 285 1.1× 28 0.2× 65 0.8× 60 1.0× 5 0.1× 36 515
Lukman Hakim Indonesia 12 125 0.5× 81 0.5× 148 1.9× 19 0.3× 4 0.1× 72 393
Ester Valentina Cafà Italy 11 201 0.8× 48 0.3× 32 0.4× 39 0.6× 6 0.1× 19 527
Amit S. Kulkarni United States 13 50 0.2× 34 0.2× 79 1.0× 52 0.8× 28 0.5× 22 479
Ahmet Hakan Haliloğlu Türkiye 12 171 0.7× 69 0.4× 98 1.3× 19 0.3× 4 0.1× 38 424
B. Campo Italy 12 253 1.0× 81 0.5× 157 2.0× 39 0.6× 2 0.0× 27 463

Countries citing papers authored by G. Viggiano

Since Specialization
Citations

This map shows the geographic impact of G. Viggiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Viggiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Viggiano more than expected).

Fields of papers citing papers by G. Viggiano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Viggiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Viggiano. The network helps show where G. Viggiano may publish in the future.

Co-authorship network of co-authors of G. Viggiano

This figure shows the co-authorship network connecting the top 25 collaborators of G. Viggiano. A scholar is included among the top collaborators of G. Viggiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Viggiano. G. Viggiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cardillo, Giuseppe, G. Viggiano, Vincenzo Russo, et al.. (2021). Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. Journal of Blood Medicine. Volume 12. 69–75. 19 indexed citations
2.
Russo, Vincenzo, Giuseppe Cardillo, G. Viggiano, et al.. (2020). Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study. Frontiers in Medicine. 7. 569567–569567. 18 indexed citations
3.
Russo, Vincenzo, Giuseppe Cardillo, G. Viggiano, et al.. (2020). Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience. Journal of Cardiovascular Pharmacology. 76(4). 369–371. 23 indexed citations
4.
Micco, P. Di, G. Viggiano, Andrea Fontanella, et al.. (2007). Upper limb deep vein thrombosis: update on risk factors in oncological patients. 5. 391–394.
5.
Optale, Gabriele, et al.. (1999). PET Supports the Hypothesized Existence of a Male Sexual Brain Algorithm that May Respond to Treatment Combining Psychotherapy with Virtual Reality. CyberPsychology & Behavior. 2(2). 157–159. 16 indexed citations
6.
Optale, Gabriele, et al.. (1998). Virtual Environments in the Treatment of Impotence and Premature Ejaculation. CyberPsychology & Behavior. 1(3). 213–216. 10 indexed citations
7.
Optale, Gabriele, et al.. (1998). A VR based therapy for the treatment of impotence and premature ejaculation.. PubMed. 58. 136–9. 11 indexed citations
8.
Optale, Gabriele, et al.. (1997). Multimedia and virtual reality techniques in the treatment of male erectile disorders. International Journal of Impotence Research. 9(4). 197–203. 39 indexed citations
9.
10.
Pavone‐Macaluso, M., F.H. Schröder, H. J. de Voogt, et al.. (1989). EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.. PubMed. 303. 111–6. 2 indexed citations
11.
Pavone‐Macaluso, M., et al.. (1987). Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.. PubMed. 243A. 379–82. 4 indexed citations
12.
13.
Dalesio, Otilia, Claude C. Schulman, R. Sylvester, et al.. (1983). Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. The Journal of Urology. 129(4). 730–733. 128 indexed citations
14.
Schulman, Claude C., L. Denis, Philip H. Smith, et al.. (1982). Prophylactic Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:an EORTC Randomized Trial Comparing Thiotepa, anEpipodophyllotoxin (VM26) and TUR Alone. European Urology. 8(4). 207–212. 67 indexed citations
15.
Viggiano, G., et al.. (1979). La Terapia Chirurgica Del Carcinoma Renale Bilaterale. Urologia Journal. 46(5). 700–711. 1 indexed citations
16.
Viggiano, G., et al.. (1975). La Nostra Esperienza Nella Chemioterapia E Chemioprofilassi Delle Neoplasie Papillari Della Vescica Con Tio-Tepa (). Urologia Journal. 42(4). 306–312. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. M. Dubernard Breakdown of academic impact, for papers by Robert Nathan Slotnick Breakdown of academic impact, for papers by Paul Fredlund Breakdown of academic impact, for papers by Pietro Cignini Breakdown of academic impact, for papers by Lois Eva Breakdown of academic impact, for papers by Lukman Hakim Breakdown of academic impact, for papers by Ester Valentina Cafà Breakdown of academic impact, for papers by Amit S. Kulkarni Breakdown of academic impact, for papers by Ahmet Hakan Haliloğlu Breakdown of academic impact, for papers by B. Campo
Rankless by CCL
2026